The Valley Desk

Clinical trial reportAIDS (London, England)Published

Galantamine for 12 weeks does not improve neurocognition or immune activation in ART-suppressed people with HIV

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Clinical trial report
Venue
AIDS (London, England)
Published
Subject terms
Monocytes; Humans; HIV Infections; Galantamine; Placebos; Treatment Outcome; Cross-Over Studies; Double-Blind Method; Cognition; Adult; Middle Aged; Female
PubMed ID
41427614
Added to directory
Source checked

Report a correction or request removal